430 related articles for article (PubMed ID: 28644440)
21. Androgen receptor regulates ASS1P3/miR-34a-5p/ASS1 signaling to promote renal cell carcinoma cell growth.
Wang K; Sun Y; Guo C; Liu T; Fei X; Chang C
Cell Death Dis; 2019 Apr; 10(5):339. PubMed ID: 31000693
[TBL] [Abstract][Full Text] [Related]
22. Long non-coding RNA HOTTIP promotes renal cell carcinoma progression through the regulation of the miR-615/IGF-2 pathway.
Wang Q; Wu G; Zhang Z; Tang Q; Zheng W; Chen X; Chen F; Li Q; Che X
Int J Oncol; 2018 Nov; 53(5):2278-2288. PubMed ID: 30226576
[TBL] [Abstract][Full Text] [Related]
23. Long noncoding RNA MRCCAT1 promotes metastasis of clear cell renal cell carcinoma via inhibiting NPR3 and activating p38-MAPK signaling.
Li JK; Chen C; Liu JY; Shi JZ; Liu SP; Liu B; Wu DS; Fang ZY; Bao Y; Jiang MM; Yuan JH; Qu L; Wang LH
Mol Cancer; 2017 Jun; 16(1):111. PubMed ID: 28659173
[TBL] [Abstract][Full Text] [Related]
24. A positive feed-forward loop between LncRNA-URRCC and EGFL7/P-AKT/FOXO3 signaling promotes proliferation and metastasis of clear cell renal cell carcinoma.
Zhai W; Zhu R; Ma J; Gong D; Zhang H; Zhang J; Chen Y; Huang Y; Zheng J; Xue W
Mol Cancer; 2019 Apr; 18(1):81. PubMed ID: 30953521
[TBL] [Abstract][Full Text] [Related]
25. miR-28-5p acts as a tumor suppressor in renal cell carcinoma for multiple antitumor effects by targeting RAP1B.
Wang C; Wu C; Yang Q; Ding M; Zhong J; Zhang CY; Ge J; Wang J; Zhang C
Oncotarget; 2016 Nov; 7(45):73888-73902. PubMed ID: 27729617
[TBL] [Abstract][Full Text] [Related]
26. CircRNA cRAPGEF5 inhibits the growth and metastasis of renal cell carcinoma via the miR-27a-3p/TXNIP pathway.
Chen Q; Liu T; Bao Y; Zhao T; Wang J; Wang H; Wang A; Gan X; Wu Z; Wang L
Cancer Lett; 2020 Jan; 469():68-77. PubMed ID: 31629934
[TBL] [Abstract][Full Text] [Related]
27. miR-144-3p serves as a tumor suppressor for renal cell carcinoma and inhibits its invasion and metastasis by targeting MAP3K8.
Liu F; Chen N; Xiao R; Wang W; Pan Z
Biochem Biophys Res Commun; 2016 Nov; 480(1):87-93. PubMed ID: 27717821
[TBL] [Abstract][Full Text] [Related]
28. Biological function and mechanism of MALAT-1 in renal cell carcinoma proliferation and apoptosis: role of the MALAT-1-Livin protein interaction.
Chen S; Ma P; Zhao Y; Li B; Jiang S; Xiong H; Wang Z; Wang H; Jin X; Liu C
J Physiol Sci; 2017 Sep; 67(5):577-585. PubMed ID: 27655020
[TBL] [Abstract][Full Text] [Related]
29. Kidney cancer: AR promotes RCC via lncRNA interaction.
Fenner A
Nat Rev Urol; 2016 May; 13(5):242. PubMed ID: 27041208
[No Abstract] [Full Text] [Related]
30. LncRNA NONHSAT113026 represses renal cell carcinoma tumorigenesis through interacting with NF-κB/p50 and SLUG.
Pu Y; Dong Z; Xia Y; Zhang M; Song J; Han J; Liu H
Biomed Pharmacother; 2019 Oct; 118():109382. PubMed ID: 31545257
[TBL] [Abstract][Full Text] [Related]
31. LncRNA SNHG1 regulates immune escape of renal cell carcinoma by targeting miR-129-3p to activate STAT3 and PD-L1.
Tian P; Wei JX; Li J; Ren JK; Yang JJ
Cell Biol Int; 2021 Jul; 45(7):1546-1560. PubMed ID: 33739543
[TBL] [Abstract][Full Text] [Related]
32. Long noncoding RNA HOTAIR promotes renal cell carcinoma malignancy through alpha-2, 8-sialyltransferase 4 by sponging microRNA-124.
Pan Y; Wu Y; Hu J; Shan Y; Ma J; Ma H; Qi X; Jia L
Cell Prolif; 2018 Dec; 51(6):e12507. PubMed ID: 30105850
[TBL] [Abstract][Full Text] [Related]
33. Depletion of the triggering receptor expressed on myeloid cells 2 inhibits progression of renal cell carcinoma via regulating related protein expression and PTEN-PI3K/Akt pathway.
Zhang H; Sheng L; Tao J; Chen R; Li Y; Sun Z; Qian W
Int J Oncol; 2016 Dec; 49(6):2498-2506. PubMed ID: 27779645
[TBL] [Abstract][Full Text] [Related]
34. LncRNA PCGEM1 promotes renal carcinoma progression by targeting miR-433-3p to regulate FGF2 expression.
Cai X; Zhang X; Mo L; Zhu J; Yu H
Cancer Biomark; 2020; 27(4):493-504. PubMed ID: 31958075
[TBL] [Abstract][Full Text] [Related]
35. MicroRNA-509-3p inhibits cancer cell proliferation and migration by targeting the mitogen-activated protein kinase kinase kinase 8 oncogene in renal cell carcinoma.
Su Z; Chen D; Zhang E; Li Y; Yu Z; Shi M; Jiang Z; Ni L; Yang S; Gui Y; Ye J; Lai Y
Mol Med Rep; 2015 Jul; 12(1):1535-43. PubMed ID: 25815776
[TBL] [Abstract][Full Text] [Related]
36. Targeting the TR4 nuclear receptor-mediated lncTASR/AXL signaling with tretinoin increases the sunitinib sensitivity to better suppress the RCC progression.
Shi H; Sun Y; He M; Yang X; Hamada M; Fukunaga T; Zhang X; Chang C
Oncogene; 2020 Jan; 39(3):530-545. PubMed ID: 31501521
[TBL] [Abstract][Full Text] [Related]
37. LncRNA SNHG17 promotes tumor progression and predicts poor survival in human renal cell carcinoma via sponging miR-328-3p.
Wu J; Dong G; Liu T; Zhang S; Sun L; Liang W
Aging (Albany NY); 2021 Sep; 13(17):21232-21250. PubMed ID: 34497156
[TBL] [Abstract][Full Text] [Related]
38. DNA-methylation-mediated repression of miR-766-3p promotes cell proliferation via targeting SF2 expression in renal cell carcinoma.
Chen C; Xue S; Zhang J; Chen W; Gong D; Zheng J; Ma J; Xue W; Chen Y; Zhai W; Zheng J
Int J Cancer; 2017 Nov; 141(9):1867-1878. PubMed ID: 28657135
[TBL] [Abstract][Full Text] [Related]
39. Sunitinib increases the cancer stem cells and vasculogenic mimicry formation via modulating the lncRNA-ECVSR/ERβ/Hif2-α signaling.
He M; Yang H; Shi H; Hu Y; Chang C; Liu S; Yeh S
Cancer Lett; 2022 Jan; 524():15-28. PubMed ID: 34461182
[TBL] [Abstract][Full Text] [Related]
40. Long non-coding RNA XIST regulates miR-106b-5p/P21 axis to suppress tumor progression in renal cell carcinoma.
Sun K; Jia Z; Duan R; Yan Z; Jin Z; Yan L; Li Q; Yang J
Biochem Biophys Res Commun; 2019 Mar; 510(3):416-420. PubMed ID: 30717973
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
